CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that researchers presented data from clinical trials demonstrating the clinical benefits of chronic Soliris® (eculizumab) treatment in patients with atypical hemolytic uremic syndrome (aHUS) as well as new patient registry data providing further insight into optimal care for patients with paroxysmal nocturnal hemoglobinuria (PNH) at the American Society of Hematology (ASH) 55th Annual Meeting and Exposition in New Orleans. Data included: A new, comprehensive study of key aHUS biomarkers indicating that, prior to initiation of Soliris treatment, aHUS patients have severe ongoing terminal complement...
New Data Presented at ASH Annual Meeting Enhance Understanding of PNH and aHUS to Provide Optimal Care for Patients with These Life-threatening Disorders
↧
↧
Global Intravenous (IV) Iron Drugs Industry
NEW YORK, Dec. 9, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Intravenous (IV) Iron Drugs Industry http://www.reportlinker.com/p0305172/Global-Intravenous-IV-Iron-Drugs-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report analyzes the worldwide markets for Intravenous (IV) Iron Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these...
↧
DSI Denham Springs Dialysis Welcomes New Medical Director, Dr. Kimberly Williams and Plans Community Open House Event
- Patients, physicians and the public are invited to tour the facility and meet Dr. Williams on December 10th. DENHAM SPRINGS, La., Dec. 9, 2013 /PRNewswire/ -- DSI Renal, a leading provider of dialysis services for patients suffering from chronic kidney failure, would like to welcome Dr. Kimberly Williams as the Medical Director for DSI Denham Springs Dialysis Center. Members of the community, dialysis patients, their families and physicians in the Denham Springs and surrounding areas...
↧
Keryx Biopharmaceuticals to Present at the 24th Annual Oppenheimer Healthcare Conference
NEW YORK, Dec. 9, 2013 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the 24th Annual Oppenheimer Healthcare Conference, being held on Wednesday, December 11th, in New York City. Mr. Bentsur's presentation is...
↧
Siemens’ SOMATOM Force1 Challenges Limits of Conventional CT Imaging (Siemens Corporation)
(Source: Siemens Corporation) Patients with renal insufficiency benefit from major reductions in administered contrast medium Chest imaging with no breath-hold Lung cancer detection with up to 50 percent lower radiation dose "SOMATOM Force negates many aspects of CT that until now have limited its application. For example, the administration of contrast medium that proves problematic for many patients can be greatly lowered" CHICAGO--(BUSINESS WIRE)--At the 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), December 1-6 in Chicago, Siemens Healthcare (booth #1934, South Building/Lakeside Center at McCormick Place, Hall A) will introduce...
↧
↧
Inhibition of NOX4-gene can prevent or delay diabetic kidney disease >> (Universiteit Maastricht)
(Source: Universiteit Maastricht) Press release 5 December 2013 The enzyme NOX4 is an important driver of kidney injury in diabetes and that inhibiting NOX4 can prevent or delay diabetic kidney disease. This has been demonstrated by an Australian-Dutch research team led by prof.dr. Harald Schmidt from Maastricht University and prof.dr. Karin Jandeleit-Dahm from the Baker IDI Heart & Diabetes Institute in Melbourne. The results will be presented this week during the World Diabetes Congress in Melbourne, and have been...
↧
Do you know anything about your kidneys?
Survey after survey has proven that Mumbaikars have weak kidneys. Here's a quiz to test how well you know the filtration units of your body Last month, a news report had the BMC admit that Mumbai is suffering an 80 per cent shortage of dialysis beds. Several patients, unable to access dialysis, have succumbed to kidney failure. With lifestyle disorders on the rise among urban Indians, it's especially important to take care of your kidneys (so what if you have a pair?). For that, you'll have to know the bean-shaped filters of your body inside...
↧
Why You Should Be Bullish On Keryx Biopharmaceuticals
Keryx Biopharmaceuticals (KERX) has grown over 350% since the beginning of this year, primarily due to clinical trial data on their chronic kidney disease drug (CKD) Zerenex. The company's quarterly earnings, along with positive trial results in November, brought the stock even higher. However, on Dec. 5, the stock plummeted more than 10% after Adam Feuerstein, a senior columnist on TheStreet.com, tweeted his prediction that Keryx was unlikely to receive new chemical entity (NCE) designation because a competitor's drug, Velphoro, was unable to earn the title. This allegation, as pointed out by several tweeters, appears to be largely baseless. Although Zerenex is pending...
↧
Research and Markets: Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2013
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/h9hzpd/hyperphosphatemia) has announced the addition of the "Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2013" report to their offering. 'Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hyperphosphatemia In Chronic Kidney Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hyperphosphatemia In Chronic Kidney...
↧
↧
Research and Development Prospect of China Dialysis Market, 2013-2017
Reportbuyer.com just published a new market research report: Research and Development Prospect of China Dialysis Market, 2013-2017. London (PRWEB) December 04, 2013 “Research and Development Prospect of China Dialysis Market, 2013-2017” firstly conducts a profound analysis on the market status, policy environment, existing problems and favorable factors of China’s dialysis industry; this report also summarizes the latest development situation of international and domestic key enterprise, and finally launches a forecast for this industry’s future development, which can provide decision-making reference for the enterprises and investors. In 2012, the scale of China’s dialysis market was about...
↧
Siemens’ SOMATOM Force1 Challenges Limits of Conventional CT Imaging
CHICAGO--(BUSINESS WIRE)--At the 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), December 1-6 in Chicago, Siemens Healthcare (booth #1934, South Building/Lakeside Center at McCormick Place, Hall A) will introduce SOMATOM® Force – the next generation in Dual Source computed tomography, which enables considerably faster imaging, more precise diagnoses, and the possibility to achieve unparalleled dose reductions for even more groups of patients. The system extends advanced CT imaging capabilities and dose-reduction features to some of the most challenging patients, e.g., patients who are very young, suffering from renal insufficiency, seriously...
↧
Keryx Biopharmaceuticals to Present at the 24th Annual Oppenheimer Healthcare Conference (Keryx Biopharmaceuticals Inc)
(Source: Keryx Biopharmaceuticals Inc) NEW YORK, Dec. 9, 2013 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the 24th Annual Oppenheimer Healthcare Conference, being held on Wednesday, December 11th, in New York City. Mr. Bentsur's presentation is scheduled to begin at 2:10...
↧
Australian scientists grow kidney from stem cells
Melbourne, Dec 16: Australian scientists claimed to have made a first complex human organ from stem cells, after growing a tiny kidney in a laboratory dish, a breakthrough that could lead to better ways of treating renal disease. The development is said to be an exciting step forward on bioengineering field that could save...
↧
↧
Kidney Diet Secrets Review | How This Book Helps People Improve Their Renal Functions Naturally - HealthReviewCenter
Kidney Diet Secrets written by Rachelle Gordon is the latest book that helps people boost their kidney function naturally without using drugs. Hector Sheldon from the site HealthReviewCenter.com performed a detailed Kidney Diet Secrets review that indicates if this book is worth buying. Seattle, WA (PRWEB) December 15, 2013 Kidney Diet Secrets is the latest book that helps people create a healthy diet plan to boost their kidney function. This book is penned by Rachelle Gordon, a veteran nurse, health consultant, and medical...
↧
>Kidney Diet Secrets Review | How This Book Helps People Improve Their Renal Functions Naturally ...
Kidney Diet Secrets written by Rachelle Gordon is the latest book that helps people boost their kidney function naturally without using drugs. Hector Sheldon from the site HealthReviewCenter.com performed a detailed Kidney Diet Secrets review that indicates if this book is worth buying. Seattle, WA (PRWEB) December 15, 2013 Kidney Diet Secrets is the latest book that helps people create a healthy diet plan to boost their kidney function. This book is penned by Rachelle Gordon, a veteran nurse, health consultant, and medical...
↧
Kidney Diet Secrets Review | How This Book Helps People Improve Their Renal Functions Naturally ...
Kidney Diet Secrets written by Rachelle Gordon is the latest book that helps people boost their kidney function naturally without using drugs. Hector Sheldon from the site HealthReviewCenter.com performed a detailed Kidney Diet Secrets review that indicates if this book is worth buying. Seattle, WA (PRWEB) December 15, 2013 Kidney Diet Secrets is the latest book that helps people create a healthy diet plan to boost their kidney function. This book is penned by Rachelle Gordon, a veteran nurse, health consultant, and medical...
↧
UQ kidney breakthrough a step forward in bioengineering
Queensland scientists have grown a kidney from stem cells, heralding a potential blockbuster weapon in the fight against renal disease. The University of Queensland breakthrough is an exciting step forward on the path of bioengineering – that is, growing new organs. Melissa Little from UQ’s Institute for Molecular Bioscience said the team designed a...
↧
↧
FDA Grants Approval of IND to Commence a Phase 3 Pivotal Study for ST10 for the Treatment of Iron Deficiency Anaemia in Chronic Kidney Disease
LONDON, December 16, 2013 /PRNewswire/ -- Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that the US Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia (IDA) in pre-dialysis patients with chronic kidney disease (CKD). The Company plans to initiate the Phase 3 study in the US in H1 2014 and positive data would be the...
↧
DaVita Patient Vaccinations Exceed Goals
DENVER--(BUSINESS WIRE)--DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, announced that the company has exceeded its goal of vaccinating 90 percent of its dialysis patients for influenza and pneumonia this flu season. As of Nov. 18, DaVita had vaccinated 91.6 percent of its patients for influenza and 92.3 percent of its patients for pneumonia. DaVita recognizes that vaccinations are critical for protection against viruses in kidney patients and therefore offers the vaccines at no cost to patients. To reach the 90 percent goal, DaVita teammates and attending physicians worked together to educate patients on the importance of...
↧
Siemens' SOMATOM Force1 Challenges Limits of Conventional CT Imaging
At the 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), December 1-6 in Chicago, Siemens Healthcare (booth #1934, South Building/Lakeside Center at McCormick Place, Hall A) will introduce SOMATOM® Force – the next generation in Dual Source computed tomography, which enables considerably faster imaging, more precise diagnoses, and the possibility to achieve unparalleled dose reductions for even more groups of patients. The system extends advanced CT imaging capabilities and dose-reduction features to some of the most challenging patients, e.g., patients who are very young, suffering from renal insufficiency, seriously ill, or obese....
↧
More Pages to Explore .....
